Buenos Aires to New Haven: A dream trip^†

• Pages: 1-9
• First Published: 23 June 2010

The 40th anniversary of the National Institute on Alcoholism and Alcohol Abuse: The impact on liver disease^†

• Pages: 10-12
• First Published: 23 June 2010

To TWEAK, or not to TWEAK: That is the question^†‡

• Pages: 13-15
• First Published: 23 June 2010

In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice^†

• Pages: 16-24
• First Published: 23 June 2010

Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice^†

• Pages: 25-32
• First Published: 23 June 2010

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes^†

• Pages: 33-37
• First Published: 23 June 2010

Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: Impact of obesity and ethnicity^†

• Pages: 38-46
• First Published: 23 June 2010

Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection^†

• Pages: 47-59
• First Published: 23 June 2010

Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus–related hepatocellular carcinoma by targeting DNA methyltransferase 1^†

• Pages: 60-70
• First Published: 23 June 2010

Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: A meta-analysis of the risk factors^†

• Pages: 71-78
• First Published: 23 June 2010

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease^†

• Pages: 79-104
• First Published: 23 June 2010

Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide^†

• Pages: 105-114
• First Published: 23 June 2010

Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells^†

• Pages: 115-125
• First Published: 23 June 2010

Theophylline improves steroid sensitivity in acute alcoholic hepatitis^†

• Pages: 126-131
• First Published: 23 June 2010

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States^†

• Pages: 132-141
• First Published: 23 June 2010

Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage^†

• Pages: 142-154
• First Published: 23 June 2010

Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications^†‡

• Pages: 155-163
• First Published: 23 June 2010

Overexpression of aspartyl-(asparaginyl)-β-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome^†

• Pages: 164-173
• First Published: 23 June 2010

Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma^†

• Pages: 174-182
• First Published: 23 June 2010

CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma^†

• Pages: 183-196
• First Published: 23 June 2010

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression^†

• Pages: 197-203
• First Published: 23 June 2010

Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation^†

• Pages: 204-214
• First Published: 23 June 2010

Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor β receptor II improves colitis but exacerbates autoimmune cholangitis^†

• Pages: 215-222
• First Published: 23 June 2010

Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene–gene interaction^†

• Pages: 223-229
• First Published: 23 June 2010

Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding^†

• Pages: 230-237
• First Published: 23 June 2010

Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis^†

• Pages: 238-248
• First Published: 23 June 2010

Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method^†

• Pages: 249-255
• First Published: 23 June 2010

Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy^†

• Pages: 256-265
• First Published: 23 June 2010

Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress^†

• Pages: 266-277
• First Published: 23 June 2010

Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells^†

• Pages: 278-290
• First Published: 23 June 2010

Tumor necrosis factor–like weak inducer of apoptosis is a mitogen for liver progenitor cells^†‡

• Pages: 291-302
• First Published: 23 June 2010

Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury^†‡

• Pages: 303-312
• First Published: 23 June 2010

Liver sinusoidal endothelium: A microenvironment-dependent differentiation program in rat including the novel junctional protein liver endothelial differentiation-associated protein-1^†

• Pages: 313-326
• First Published: 23 June 2010

Regulation of multidrug resistance-associated protein 2 by calcium signaling in mouse liver^†

• Pages: 327-337
• First Published: 23 June 2010

Bid agonist regulates murine hepatocyte proliferation by controlling endoplasmic reticulum calcium homeostasis^†

• Pages: 338-348
• First Published: 23 June 2010

American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis^†

• Pages: 349-359
• First Published: 23 June 2010

Sorafenib: Where do we go from here?^†

• Pages: 360-369
• First Published: 23 June 2010

Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease^†‡

• Pages: 370-380
• First Published: 23 June 2010

Toward small animal models for the study of human hepatitis viruses^†

• Pages: 381-384
• First Published: 25 June 2010

Pre-“EMT”ing key processes in liver carcinogenesis: Growing evidence for how malignant hepatocytes invade and conquer^†

• Pages: 384-388
• First Published: 25 June 2010

Another cause of autoimmune hepatitis^†

• Pages: 389-390
• First Published: 23 June 2010

Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease^†

• Page: 391
• First Published: 23 June 2010

Reply: Cigarette Smoking Is Not Associated with Specific Histological Features or Severity of Nonalcoholic Fatty Liver Disease^†

• Pages: 391-392
• First Published: 23 June 2010

Ferritin and liver allocation? Impact on mortality not only on the waiting list but also after orthotopic liver transplantation should be considered^†

• Pages: 392-393
• First Published: 23 June 2010

Reply: Ferritin and Liver Allocation? Impact on Mortality Not Only on the Waiting List But Also After Orthotopic Liver Transplantation Should Be Considered^†

• Page: 393
• First Published: 23 June 2010

Diagnostic utility of chromosome 17 and p16 abnormalities in fluorescence in situ hybridization tests in primary sclerosing cholangitis^†

• Pages: 393-394
• First Published: 25 June 2010

Reply: Diagnostic Utility of Chromosome 17 and p16 Abnormalities in Fluorescence In Situ Hybridization Tests in Primary Sclerosing Cholangitis^†

• Pages: 394-395
• First Published: 23 June 2010

Methodological issues in a meta-analysis^†

• Pages: 395-396
• First Published: 25 June 2010

Reply: Methodological issues in a meta-analysis^†

• Pages: 396-397
• First Published: 25 June 2010

Routine hepatitis B virus DNA testing in patients with human immunodeficiency virus^†

• Page: 397
• First Published: 23 June 2010

Think twice if you consider entecavir treatment in cases with lamivudine refractoriness^†

• Pages: 397-398
• First Published: 23 June 2010

Hemochromatosis protein HFE C282Y conformational considerations^†

• Pages: 398-399
• First Published: 23 June 2010

Natural approach against lipotoxic traffic in nonalcoholic fatty liver disease^†

• Page: 399
• First Published: 23 June 2010

Genetic variations in heme oxygenase-1 and chronic hepatitis^†

• Pages: 400-401
• First Published: 23 June 2010

Quantification of genotype 4 serum samples: Impact of hepatitis C virus genetic variability^†

• Page: 401
• First Published: 23 June 2010

• Page: 402
• First Published: 23 June 2010

• Page: 402
• First Published: 23 June 2010

• Page: 402
• First Published: 25 June 2010